Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0002020260-24-000002
Filing Date
2024-10-02
Accepted
2024-10-02 17:19:39
Documents
1
Period of Report
2024-10-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1727903970.html 4  
1 FORM 4 wk-form4_1727903970.xml 4 4989
  Complete submission text file 0002020260-24-000002.txt   6747
Mailing Address 110 ALLEN ROAD SECOND FLOOR BASKING RIDGE NJ 07920
Business Address 110 ALLEN ROAD SECOND FLOOR BASKING RIDGE NJ 07920 908-229-2590
LISATA THERAPEUTICS, INC. (Issuer) CIK: 0000320017 (see all company filings)

EIN.: 222343568 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 110 ALLEN ROAD 2ND FLOOR BASKING RIDGE NJ 07920
Business Address
Nisco James (Reporting) CIK: 0002020260 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33650 | Film No.: 241348829